Lois M Ramondetta1, Larissa A Meyer2, Kathleen M Schmeler2, Maria E Daheri3, Jessica Gallegos2, Michael Scheurer4, Jane R Montealegre4, Andrea Milbourne2, Matthew L Anderson5, Charlotte C Sun2. 1. Department of Gynecologic Oncology and Reproductive Medicine, M. D. Anderson Cancer Center, Houston, TX 77030, United States; Lyndon Baines Hospital, Division Gynecologic Oncology, Harris Health System, Houston, TX 77026, United States. Electronic address: lramonde@mdanderson.org. 2. Department of Gynecologic Oncology and Reproductive Medicine, M. D. Anderson Cancer Center, Houston, TX 77030, United States; Lyndon Baines Hospital, Division Gynecologic Oncology, Harris Health System, Houston, TX 77026, United States. 3. Cervical Cancer Case Management, Harris Health System, Houston, TX 77054, United States. 4. Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States. 5. Departments of Obstetrics & Gynecology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States.
Abstract
BACKGROUND: The purpose was to identify barriers including logistical and health belief correlates of late stage presentation of cervical cancer (CxCa) among medically underserved women presenting to a safety net health care system. METHODS: Women presenting with newly diagnosed CxCa were asked to complete a detailed health belief survey that included questions about barriers to care and their knowledge of CxCa. All information was collected prior to initiating cancer treatment. Comparisons were made among women diagnosed at early stages of disease amendable to surgical treatment (≤IB1) and those diagnosed at a stage requiring local-regional or systemic/palliative treatment (≥IB2). RESULTS: Among the 138 women, 21.7% were diagnosed with ≤lB1 disease, while 78.3% were diagnosed with ≥IB2 disease. Late-stage diagnosis was associated with a greater number of emergency room (ER) visits (p<.001) and blood transfusions (p<.001) prior to diagnosis. Compared to 88% with ≤lB1 disease, only 53% of patients with ≥IB2 disease had a car (p=.003). Women with ≥IB2 disease were more likely to be without a primary care provider (75.0% vs. 42.3%, p=.001). CONCLUSION: Access to transportation and lack of a regular primary care provider or a medical home are associated with late-stage of CxCa at diagnosis. Many medically underserved women continue to use the ER as their primary source of health care, and as a result their CxCa is diagnosed in advanced stages, with higher medical costs and lower chances of cure. The lack of Medicaid expansion in Texas may result in a worsening of this situation.
BACKGROUND: The purpose was to identify barriers including logistical and health belief correlates of late stage presentation of cervical cancer (CxCa) among medically underserved women presenting to a safety net health care system. METHODS:Women presenting with newly diagnosed CxCa were asked to complete a detailed health belief survey that included questions about barriers to care and their knowledge of CxCa. All information was collected prior to initiating cancer treatment. Comparisons were made among women diagnosed at early stages of disease amendable to surgical treatment (≤IB1) and those diagnosed at a stage requiring local-regional or systemic/palliative treatment (≥IB2). RESULTS: Among the 138 women, 21.7% were diagnosed with ≤lB1 disease, while 78.3% were diagnosed with ≥IB2 disease. Late-stage diagnosis was associated with a greater number of emergency room (ER) visits (p<.001) and blood transfusions (p<.001) prior to diagnosis. Compared to 88% with ≤lB1 disease, only 53% of patients with ≥IB2 disease had a car (p=.003). Women with ≥IB2 disease were more likely to be without a primary care provider (75.0% vs. 42.3%, p=.001). CONCLUSION: Access to transportation and lack of a regular primary care provider or a medical home are associated with late-stage of CxCa at diagnosis. Many medically underserved women continue to use the ER as their primary source of health care, and as a result their CxCa is diagnosed in advanced stages, with higher medical costs and lower chances of cure. The lack of Medicaid expansion in Texas may result in a worsening of this situation.
Authors: Ian K Komenaka; Jesse N Nodora; Chiu-Hsieh Hsu; Maria Elena Martinez; Sonal G Gandhi; Marcia E Bouton; Anne E Klemens; Lauren I Wikholm; Barry D Weiss Journal: Obstet Gynecol Date: 2015-04 Impact factor: 7.661
Authors: Vicki B Benard; Cheryll C Thomas; Jessica King; Greta M Massetti; V Paul Doria-Rose; Mona Saraiya Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-07 Impact factor: 17.586
Authors: T Clark Powell; Sarah E Dilley; Sejong Bae; J Michael Straughn; Kenneth H Kim; Charles A Leath Journal: J Low Genit Tract Dis Date: 2018-10 Impact factor: 1.925
Authors: Vicki B Benard; Meg Watson; Mona Saraiya; Rhea Harewood; Julie S Townsend; Antoinette M Stroup; Hannah K Weir; Claudia Allemani Journal: Cancer Date: 2017-12-15 Impact factor: 6.860
Authors: Anna Louise Beavis; Awa Sanneh; Rebecca L Stone; Margaret Vitale; Kimberly Levinson; Anne F Rositch; Amanda Nickles Fader; Kristin Topel; Ashley Abing; Stephanie L Wethington Journal: Am J Obstet Gynecol Date: 2020-05-17 Impact factor: 8.661
Authors: David A Barrington; Sarah E Dilley; Emily E Landers; Eric D Thomas; Jonathon D Boone; J Michael Straughn; Gerald McGwin; Charles A Leath Journal: Gynecol Oncol Date: 2016-10-06 Impact factor: 5.482
Authors: John S Luque; Yelena N Tarasenko; Hong Li; Caroline B Davila; Rachel N Knight; Rosa E Alcantar Journal: J Racial Ethn Health Disparities Date: 2017-07-12
Authors: Lisa P Spees; Stephanie B Wheeler; Mahesh Varia; Morris Weinberger; Christopher D Baggett; Xi Zhou; Victoria M Petermann; Wendy R Brewster Journal: Gynecol Oncol Date: 2018-11-12 Impact factor: 5.482
Authors: Scott V Adams; Andrea N Burnett-Hartman; Andrew Karnopp; Aasthaa Bansal; Stacey A Cohen; Victoria Warren-Mears; Scott D Ramsey Journal: Am J Prev Med Date: 2016-03-24 Impact factor: 5.043
Authors: Uma D Goyal; Paras P Mehta; Susan Samreth; John Gloss; Haiyan Cui; Denise Roe; Shona Dougherty Journal: J Contemp Brachytherapy Date: 2021-05-13
Authors: Liisa Jaakkimainen; Imaan Bayoumi; Richard H Glazier; Kamila Premji; Tara Kiran; Shahriar Khan; Eliot Frymire; Michael E Green Journal: J Health Organ Manag Date: 2021-07-26